F. Moheb Afzali, “BCc1, a Chelation-Based Nanomedicine, modulates splenic cytokine networks toward a profile associated with antitumor immunity in 4T1 breast tumor–bearing mice”, Arch Adv Biosci, vol. 17, no. 1, pp. 1–13, May 2026.